Partner and affiliate terms

We do not carry a commercial link to a product whose intervention page is graded C, D, F, HARMFUL or INSUFFICIENT. If a grade falls below B, the links come down — automatically, on the grade change, not at the next commercial review.

A partner cannot appeal a grade commercially. The only route is the editorial one: bring evidence, in public, to the review board. See how we grade evidence.

• Disclosure sits at the point of the link, before the click, in the same visual context. Not in a footer, not on a separate page, not behind a tooltip.
• Plain words: "we earn a commission on this link". Not "#sp", not "affiliate" alone, not a symbol.
• The disclosure is not removable by a partner, a placement, or a campaign.

The standards behind that are the FTC Endorsement Guides in the US, the CAP Code and ASA guidance in the UK, and the ASCI Guidelines for Influencer Advertising in India. We apply the strictest of them everywhere rather than varying by market, because a disclosure rule that changes by geography is a disclosure rule people get wrong.

In this market specifically: CAP Code rules on health and beauty claims: no claim that a product can prevent, treat or cure a human disease unless it is an authorised medicine. Prescription-only medicines are never advertised to the public, which is why dosing on drug pages is reported as study exposure and never as a recommendation. Affiliate content is identifiable as advertising at the point of the link, as the ASA requires.

• An evidence grade, a change to one, or advance notice of one.
• A position in a ranked list, a comparison table, or a directory result.
• Editorial coverage, a review, or the wording of a verdict.
• The removal of a criticism, a safety note, or a correction.
• Access to member data of any kind, aggregated or otherwise.

• Commission is a fixed percentage or fixed fee agreed in advance and never varies with what we say about the product.
• We do not accept payment for placement in editorial content, and we do not run advertorial.
• Prices, stock and delivery are the partner’s. We do not set them and we do not take a share of a price increase.
• Either side can end the arrangement with 30 days’ notice. Links come down; published editorial about the product stays up, unchanged.

• Partners must keep their product claims within what their own market authorises, and must tell us within five working days of a regulatory action affecting a linked product.
• We audit our own links quarterly against current grades and publish the grade floor rule so anyone can check it.
• A partner that misrepresents our grades, or implies our endorsement, is removed immediately and we say why on the affected pages.